These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 2781141)

  • 1. Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.
    D'mello A; Venkataramanan R; Satake M; Todo S; Takaya S; Ptachcinski RJ; Burckart GJ; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):441-54. PubMed ID: 2781141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole inhibits cyclosporine metabolism in vivo in mice.
    Anderson JE; Blaschke TF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):671-4. PubMed ID: 3950868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.
    First MR; Schroeder TJ; Alexander JW; Stephens GW; Weiskittel P; Myre SA; Pesce AJ
    Transplantation; 1991 Feb; 51(2):365-70. PubMed ID: 1994529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo investigation in pigs of intestinal absorption, hepatobiliary disposition, and metabolism of the 5α-reductase inhibitor finasteride and the effects of coadministered ketoconazole.
    Lundahl A; Hedeland M; Bondesson U; Lennernäs H
    Drug Metab Dispos; 2011 May; 39(5):847-57. PubMed ID: 21317368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine.
    Gomez DY; Wacher VJ; Tomlanovich SJ; Hebert MF; Benet LZ
    Clin Pharmacol Ther; 1995 Jul; 58(1):15-9. PubMed ID: 7628178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
    Bruelisauer A; Kawai R; Misslin P; Lemaire M
    Drug Metab Dispos; 1994; 22(2):194-9. PubMed ID: 8013274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of azole antifungal agents. I. Nonlinearities in ketoconazole clearance and binding in rat liver.
    Matthew D; Brennan B; Zomorodi K; Houston JB
    Pharm Res; 1993 Mar; 10(3):418-22. PubMed ID: 8464816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and metabolism of cyclosporin; drug interactions].
    Le Bigot JF; Lavene D; Kiechel JR
    Nephrologie; 1987; 8(3):135-41. PubMed ID: 3658089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ketoconazole on the pharmacokinetics of cyclosporine A in cats.
    McAnulty JF; Lensmeyer GL
    Vet Surg; 1999; 28(6):448-55. PubMed ID: 10582742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine disposition in the dog. Comparison of radioimmunoassay with high-performance liquid chromatographic assay and pharmacokinetics following intravenous administration.
    Buice RG; Gurley BJ; Stentz FB; Sidhu P; McClellan T; Williams JW
    Transplantation; 1985 Nov; 40(5):483-8. PubMed ID: 4060219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition and pharmacokinetics of ketoconazole in the rat.
    Remmel RP; Amoh K; Abdel-Monem MM
    Drug Metab Dispos; 1987; 15(6):735-9. PubMed ID: 2893696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
    Kuroha M; Shirai Y; Shimoda M
    J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine kinetics in healthy volunteers.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Gray JA; Van Thiel DH; Sanghvi A; Rosenthal JT
    J Clin Pharmacol; 1987 Mar; 27(3):243-8. PubMed ID: 3680581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin.
    Hugnet C; Lespine A; Alvinerie M
    J Pharm Pharm Sci; 2007; 10(3):311-8. PubMed ID: 17727794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of bioavailability of the HIV protease inhibitor SC-52151 in the beagle dog by coadministration of the CYP3A4 inhibitor, ketoconazole.
    Yuan JH; Stolzenbach JC; Salamon CM; Snook SS; Schoenhard GL
    Xenobiotica; 1997 May; 27(5):489-97. PubMed ID: 9179989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical ketoconazole dosage range for ciclosporin clearance inhibition in the dog.
    Myre SA; Schoeder TJ; Grund VR; Wandstrat TL; Nicely PG; Pesce AJ; First MR
    Pharmacology; 1991; 43(5):233-41. PubMed ID: 1784623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-phenytoin interaction.
    D'Souza MJ; Pollock SH; Solomon HM
    Drug Metab Dispos; 1988; 16(2):256-8. PubMed ID: 2898343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis.
    Tredger JM; Grevel J; Naoumov N; Steward CM; Niven AA; Whiting B; Williams R
    Eur J Clin Pharmacol; 1991; 40(5):513-9. PubMed ID: 1884727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and clinical tolerance of intravenous and oral cyclosporine in the immediate postoperative period.
    Morse GD; Holdsworth MT; Venuto RC; Gerbasi J; Walshe JJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):654-64. PubMed ID: 3058372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.